Jeppson Wealth Management LLC Has $501,000 Stake in The Clorox Company (NYSE:CLX)

Jeppson Wealth Management LLC reduced its holdings in The Clorox Company (NYSE:CLX) by 6.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,083 shares of the company’s stock after selling 200 shares during the quarter. Jeppson Wealth Management LLC’s holdings in Clorox were worth $501,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. IRON Financial LLC increased its position in Clorox by 2.8% in the 4th quarter. IRON Financial LLC now owns 5,512 shares of the company’s stock worth $895,000 after buying an additional 151 shares during the period. Slow Capital Inc. grew its stake in shares of Clorox by 0.8% in the fourth quarter. Slow Capital Inc. now owns 18,462 shares of the company’s stock worth $2,998,000 after acquiring an additional 142 shares during the last quarter. Webster Bank N. A. increased its position in Clorox by 36.8% during the fourth quarter. Webster Bank N. A. now owns 520 shares of the company’s stock worth $84,000 after acquiring an additional 140 shares during the period. United Asset Strategies Inc. raised its stake in Clorox by 1.2% during the 4th quarter. United Asset Strategies Inc. now owns 32,989 shares of the company’s stock valued at $5,358,000 after purchasing an additional 402 shares during the last quarter. Finally, Cornerstone Wealth Group LLC boosted its holdings in Clorox by 3.9% in the 4th quarter. Cornerstone Wealth Group LLC now owns 21,497 shares of the company’s stock valued at $3,491,000 after purchasing an additional 801 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

NYSE:CLX opened at $162.35 on Tuesday. The firm has a market cap of $20.10 billion, a PE ratio of 56.57, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company’s 50-day moving average price is $163.66 and its two-hundred day moving average price is $157.66. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.49 EPS. Clorox’s revenue was up 27.0% compared to the same quarter last year. On average, equities analysts anticipate that The Clorox Company will post 6.87 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.01%. Clorox’s dividend payout ratio is 170.04%.

Analysts Set New Price Targets

CLX has been the subject of a number of research analyst reports. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays cut their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a report on Friday, January 17th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI cut their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday, January 16th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.